MountSinaiLiver
@MountSinaiLiver
Followers
1K
Following
2K
Statuses
656
Official account of the Division of Liver Diseases @MountSinaiNYC
New York, NY
Joined July 2017
RT @DOMSinaiNYC: #MASH affects 1 in 3 adults and 1 in 10 children, yet many remain undiagnosed. With the first #FDA-approved treatment now…
0
4
0
Josep Llovet, MD, discusses his research regarding treatment for liver cancer after drugs. Learn more: @DOMSinaiNYC
0
2
2
RT @MountSinaiGI: The Division of Gastroenterology and @MountSinaiLiver have launched HEALD to eliminate disparities in #GI and #liver care…
0
2
0
Mount Sinai researchers are exploring liquid biopsy as a breakthrough tool for early detection of hepatocellular carcinoma, comparing it to current standards like ultrasound and serum AFP. This innovative approach could transform early cancer detection.
0
3
10
RT @BhavanaBRaoMD: Fellowship is a period where so much life happens and that’s why having this kind of group of co- fellows for family can…
0
2
0
RT @DOMSinaiNYC: The new Mount Sinai Institute for Liver Research aims to discover new therapies for liver disease. After 23 years as Chief…
0
1
0
RT @DOMSinaiNYC: Join us for this insightful virtual symposium as leading experts in liver diseases come together to discuss the latest dev…
0
1
0
RT @LiverEmpire: Check out #EmpireLiverFoundation member, Dr. Tatyana Kushner, MD, MSCE, @TatyanaKushner, of @IcahnMountSinai @MountSinaiLi…
0
3
0
Douglas Dieterich, MD, discusses the use of a new #FDA-approved drug to treat an autoimmune #cholestatic #liver disease. "This is a giant step forward in providing effective treatment options for patients suffering from this condition." @DOMSinaiNYC
0
1
1
Honoring Excellence in Liver Disease Research 🌟 On May 22, 2024, we celebrated the prestigious Fenton Schaffner Lectureship, recognizing the groundbreaking contributions of Dr. Fenton Schaffner, the Founding Chief of the Division of Liver Diseases at Mount Sinai. #LiverMedicine
0
3
24
On June 1, 2024, we proudly joined the Liver Life Walk NYC with 34 teams and 294 walkers. Huge thanks to Dr. Douglas Dieterich, this year's Medical Chair. Grateful to everyone who participated and supported us. #LiverLifeWalk #Gratitude #ALF @DOMSinaiNYC @liverUSA
0
2
8
RT @bcm_gihep: Proud to have the pioneer of fibrosis pathway #scottfriedman @MountSinaiLiver on our GI grand rounds
0
3
0
RT @AST_LICOP: Welcome one of our newest members of #LICOP⭐️ @dinaszaret👏 She will start a GI-palliative combined fellow program @MountSin…
0
5
0
Douglas Dieterich, MD, explains the differences between hepatitis C and B, how they are transmitted and treated, who is at risk, and why all adults should be screened for hepatitis. #HepatitisC #HepatitisB #Hepatitis #HCV #HBV @DOMSinaiNYC
0
1
2
0
2
0
@HispanicFed A2: Everyone should get tested for Hep C and B at least once, regardless of risk factors, as they can lead to liver damage or cancer. Mount Sinai is testing everyone, increasing awareness, and our LEAP team supports patients throughout treatment. #hepfreenyc #NYCHepElimination
0
1
2
@HispanicFed A8: We will continue to work on increasing screening, linkage to care, and treatment rates for patients. We will also continue to engage primary care providers around screening and to build community relationships to facilitate referrals. #hepfreenyc #NYCHepElimination #EndHepNYC
1
1
2
@HispanicFed A6: Our multilingual LEAP team of coordinators supports patients who test positive. Call 212-824-9726 or email hepb@mssm.edu or hepc@mssm.edu to connect. Our HONE team does community outreach screening events and provides linkage to care for vaccines and treatment. #hepfreenyc
0
1
1